FTC on class actions
This article was originally published in The Tan Sheet
Federal courts reviewing class action "coupon" settlements should be required to determine the "realistic value of the coupons to the class," commission says in Feb. 15 letter to U.S. Judicial Conference's Committee on Rules of Practice & Procedure. Coupons complicate a court's ability to analyze proposed settlements because, "unlike monetary settlements, they are difficult to value" and "many factors come into play in such valuation, including the likelihood that consumers will actually use the coupon." FTC suggests courts consider history of coupon redemption rates in similar situations, whether all class members will be entitled to use coupons and time restrictions on redemption...
You may also be interested in...
EU Regulatory Roundup, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty
Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.
Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.
Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.